DoD Tuberous Sclerosis Complex, Clinical Translational Research Award
ID: 353646Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353646
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 19, 2024, 12:00 AM UTC
  4. 4
    Due Aug 1, 2024, 12:00 AM UTC
Description

The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award. This grant aims to support innovative studies that advance the understanding, prevention, and treatment of Tuberous Sclerosis Complex (TSC), focusing on areas such as neuropsychiatric disorders, tumors, epilepsy, and maternal-fetal health. With an estimated total program funding of $3.4 million, the program anticipates awarding two grants, with individual budgets capped at $1 million and $1.15 million for collaborative projects. Key deadlines include a pre-application submission by June 12, 2024, and a full application due by August 1, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

Point(s) of Contact
help@eBRAP.org
Files
Title
Posted
HT942524TSCRPCTRA__GG.pdf
Aug 24, 2024, 2:22 AM UTC
The Department of Defense (DOD) announces its FY24 funding opportunity for the Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award. This initiative seeks applications for studies that advance understanding, prevention, and treatment of Tuberous Sclerosis Complex (TSC) with a focus on various areas including neuropsychiatric disorders, tumors associated with TSC, epilepsy, and maternal-fetal health. A total of $8 million is allocated for this funding opportunity, which aims to support research relevant to military service members, veterans, and the American public. Key deadlines include the pre-application submission by June 12, 2024, and the full application by August 1, 2024. Eligible applicants include independent researchers and organizations from both intramural and extramural settings. The awards will be made with a budget cap of $1 million for individual submissions and $1.15 million for those employing a Partnering PI option, which encourages collaboration between clinicians and research scientists. The two-tier review process involves peer evaluation based on clinical translational potential, impact, and research strategy, followed by programmatic assessment. Overall, this funding opportunity emphasizes the importance of innovative research to improve diagnostics and treatment related to TSC while adhering to stringent application guidelines.
Similar Opportunities
NFRP Outreach and Invitation for Response
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" aimed at advancing precision medicine for pregnant individuals, lactating persons, and children. This grant seeks to support innovative research that develops novel tools and technologies, enhances understanding of drug mechanisms, and improves therapeutic options for these populations, particularly those with disabilities. The initiative is part of the R21 Exploratory/Developmental Research Grants program, with a funding cap of $275,000 over a potential two-year period, and requires a Data Management and Sharing Plan as part of the application process. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
Military and Civilian Partnership for Trauma Readiness Grant Program/Mission Zero
Admin for Strategic Preparedness and Response
The Administration for Strategic Preparedness and Response is offering the Military and Civilian Partnership for Trauma Readiness Grant Program, also known as the Mission Zero Act, to support high-acuity trauma centers in enhancing military-civilian partnerships for improved trauma care. This grant program aims to award up to 30 eligible trauma centers, enabling military trauma teams to provide full-time trauma and acute care services, thereby strengthening the nation's response to public health and medical emergencies. With an estimated total program funding of $4 million and an award ceiling of $4 million per grant, interested applicants, including nonprofits without 501(c)(3) status and hospitals, should note that the application period is expected to open on January 15, 2025, with a closing date of April 14, 2025. For further inquiries, applicants can contact Leslie Beck at 301-346-4857 or via email at leslie.beck@hhs.gov.
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH), through its National Center for Advancing Translational Sciences (NCATS), has announced a funding opportunity for the Limited Competition Small Grant Program (R03), aimed at supporting Clinical and Translational Science Award (CTSA) Program KL2/K12 scholars and diversity supplement recipients. This program is designed to facilitate the transition of these scholars to independent research careers by funding small, self-contained research projects that can be conducted quickly and with limited resources, ultimately addressing inefficiencies in translational science. Grants of up to $50,000 per year are available for projects lasting up to two years, with a submission deadline of January 17, 2025, and an anticipated award cycle beginning in February 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research into the mechanisms underlying structural birth defects. This initiative encourages applicants to utilize advancements in genetics, omics methods, and synthetic biology to explore genetic, environmental, and epigenetic factors contributing to these anomalies, which affect approximately 3% of live births in the U.S. The grant allows for budgets up to $499,999 in direct costs per year, with project periods not exceeding five years, and applications are due by February 5, 2025. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
Tribal Colleges Research Grants Program
National Institute of Food and Agriculture
The National Institute of Food and Agriculture (NIFA) is offering the Tribal Colleges Research Grants Program (TCRGP) to enhance research capacity at 1994 American Indian Land-grant Institutions. This program aims to support diverse research projects that address tribal, state, or national issues, with individual grants ranging from $150,000 to $3 million, and a total funding pool of $5 million available for Fiscal Year 2025. The TCRGP emphasizes advancing diversity, equity, inclusion, and accessibility in research, requiring collaborations with approved research institutions and encouraging projects that incorporate Traditional Ecological Knowledge. Interested applicants must adhere to specific eligibility criteria and submission processes, with application deadlines on May 1, September 1, and December 31, 2025. For further inquiries, applicants can contact NIFA Support via email at grantapplicationquestions@usda.gov.
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has announced a Limited Competition funding opportunity titled the Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3), aimed at enhancing translational research through collaborative efforts among multiple medical research institutions. This initiative seeks to support the development, implementation, and dissemination of innovative solutions that address urgent public health needs and promote health equity, requiring applicants to include at least three eligible organizations to foster interdisciplinary partnerships. Eligible projects can receive funding of up to $650,000 annually for a total duration of up to five years, with applications due by October 19, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-296.html.
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research into the mechanisms underlying structural birth defects. This grant encourages applicants to utilize animal models alongside human translational and clinical approaches, focusing on genetic, epigenetic, and environmental factors that contribute to these conditions. With over 120,000 infants affected annually in the U.S., this research is critical for public health, and projects may receive funding of up to $499,999 per year for a maximum of five years. Interested applicants must submit their proposals by September 7, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/pa-files/PAR-22-215.html.
Autism Research Consortium (Autism RC)
Health Resources and Services Administration
The Health Resources and Services Administration (HRSA) is inviting applications for the Autism Research Consortium (Autism RC), aimed at supporting research that enhances the health and well-being of children and adolescents with autism. This initiative seeks to fund up to five research centers with a total budget of $5 million, providing cooperative agreements valued at up to $1 million per year for three years, focusing on innovative interventions and systems that address disparities in care. The program emphasizes the importance of partnerships with affected communities to develop evidence-based practices that improve physical and behavioral health outcomes for autistic children and their families. Applications are due by April 23, 2025, and interested parties can contact Deborah Quint Shelef and Emmie Perchak at autismrc@hrsa.gov for further information.
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Dept. of the Army -- USAMRAA
The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.